Evgen Pharma plc 8EV.F Stock
Evgen Pharma plc Price Chart
Evgen Pharma plc 8EV.F Financial and Trading Overview
| Evgen Pharma plc stock price | 0.0005 EUR |
| Previous Close | 0.02 EUR |
| Open | 0.02 EUR |
| Bid | 0.02 EUR x 0 |
| Ask | 0.05 EUR x 0 |
| Day's Range | 0.02 - 0.02 EUR |
| 52 Week Range | 0.02 - 0.06 EUR |
| Volume | 3K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 9.44M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
8EV.F Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.78846157 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Evgen Pharma plc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.06 EUR |
| 52 Week Low | 0.02 EUR |
| 50-Day Moving Average | 0.03 EUR |
| 200-Day Moving Average | 0.03 EUR |
8EV.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 274.89M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 38.83% |
| % Held by Institutions | 30.42% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 0.026 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Evgen Pharma plc
| Country | Germany |
| State | N/A |
| City | Nether Alderley |
| Address | Alderley Park, Block 24 |
| ZIP | SK10 4TG |
| Phone | 44 16 2546 6591 |
| Website | https://evgen.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company's lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the treatment of glioblastoma, as well as in preclinical stage for the treatment of haematological malignancies and analogues. It also provides out-licensing of its technology services. Evgen Pharma plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.
Q&A For Evgen Pharma plc Stock
What is a current 8EV.F stock price?
Evgen Pharma plc 8EV.F stock price today per share is 0.0005 EUR.
How to purchase Evgen Pharma plc stock?
You can buy 8EV.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Evgen Pharma plc?
The stock symbol or ticker of Evgen Pharma plc is 8EV.F.
Which industry does the Evgen Pharma plc company belong to?
The Evgen Pharma plc industry is Biotechnology.
How many shares does Evgen Pharma plc have in circulation?
The max supply of Evgen Pharma plc shares is 7.75B.
What is Evgen Pharma plc Price to Earnings Ratio (PE Ratio)?
Evgen Pharma plc PE Ratio is now.
What was Evgen Pharma plc earnings per share over the trailing 12 months (TTM)?
Evgen Pharma plc EPS is -0.01 EUR over the trailing 12 months.
Which sector does the Evgen Pharma plc company belong to?
The Evgen Pharma plc sector is Healthcare.